Overview Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indication: In combination with chemotherapy, with the treatment of adult individuals with regionally recurrent unresectable or metastatic triple-adverse breast most cancers which have not obtained prior chemotherapy for metastatic disease and whose tumours express programmed cell death-ligand 1 (combined optimistic score ... https://lenmeldy52716.mdkblog.com/41956540/keytruda-cost-things-to-know-before-you-buy